126 related articles for article (PubMed ID: 38380509)
61. Kaposi's sarcoma herpesvirus activates the hypoxia response to usurp HIF2α-dependent translation initiation for replication and oncogenesis.
Méndez-Solís O; Bendjennat M; Naipauer J; Theodoridis PR; Ho JJD; Verdun RE; Hare JM; Cesarman E; Lee S; Mesri EA
Cell Rep; 2021 Dec; 37(13):110144. PubMed ID: 34965440
[TBL] [Abstract][Full Text] [Related]
62. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
63. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
64. Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV.
Gam Ze Letova C; Kalt I; Shamay M; Sarid R
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769420
[TBL] [Abstract][Full Text] [Related]
65. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
66. Polyamine biosynthesis and eIF5A hypusination are modulated by the DNA tumor virus KSHV and promote KSHV viral infection.
Fiches GN; Wu Z; Zhou D; Biswas A; Li TW; Kong W; Jean M; Santoso NG; Zhu J
PLoS Pathog; 2022 Apr; 18(4):e1010503. PubMed ID: 35486659
[TBL] [Abstract][Full Text] [Related]
67. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
68.
Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS
J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998
[TBL] [Abstract][Full Text] [Related]
69. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
70. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.
Asha K; Balfe N; Sharma-Walia N
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102879
[TBL] [Abstract][Full Text] [Related]
71. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
72. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.
Botto S; Totonchy JE; Gustin JK; Moses AV
mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540
[TBL] [Abstract][Full Text] [Related]
73. KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.
Kumar A; Lyu Y; Yanagihashi Y; Chantarasrivong C; Majerciak V; Salemi M; Wang KH; Inagaki T; Chuang F; Davis RR; Tepper CG; Nakano K; Izumiya C; Shimoda M; Nakajima KI; Merleev A; Zheng ZM; Campbell M; Izumiya Y
Cell Rep; 2022 May; 39(6):110788. PubMed ID: 35545047
[TBL] [Abstract][Full Text] [Related]
74. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
75. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element.
An J; Lichtenstein AK; Brent G; Rettig MB
Blood; 2002 Jan; 99(2):649-54. PubMed ID: 11781250
[TBL] [Abstract][Full Text] [Related]
76. Cellular MicroRNA Let-7a Suppresses KSHV Replication through Targeting MAP4K4 Signaling Pathways.
Tan X; Gao Y; Nan Y; Zhang J; Di C; Wang X; Lian F; Cao Y; Hu Y; Xu L; Ma H; Hong Y; Liu T; Wu Y; Xu X; Yan Y; Yang L
PLoS One; 2015; 10(7):e0132148. PubMed ID: 26197270
[TBL] [Abstract][Full Text] [Related]
77. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
78. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
Ganem D
J Clin Invest; 2010 Apr; 120(4):939-49. PubMed ID: 20364091
[TBL] [Abstract][Full Text] [Related]
79. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues.
Sun R; Tan X; Wang X; Wang X; Yang L; Robertson ES; Lan K
PLoS Pathog; 2017 Jan; 13(1):e1006167. PubMed ID: 28118409
[TBL] [Abstract][Full Text] [Related]
80. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
